Following a second injection at eight weeks, the patient maintained stable vision and remained dry at 12 weeks, allowing for ...

Severe, long-standing DME with cystoid changes, subretinal detachment, and high inflammatory cytokine burden tends to respond better to dual ANG2/VEGF-A inhibition than VEGF monotherapy. Faricimab ...

Sept. 16 -- TUESDAY, Sept. 15 (HealthDay News) -- Researchers report they've found the first long-term treatment for people who suffer vision loss when the large veins in their eyes become blocked.

Swedish researchers find that daily cortisone eye drops reduce the chance that babies with ROP will require further invasive interventions ...